|1.||Percário, Sandro: 4 articles (01/2015 - 01/2006)|
|2.||Lee, Sun-Mee: 4 articles (05/2004 - 12/2002)|
|3.||McAnulty, Steven R: 3 articles (07/2013 - 03/2008)|
|4.||Erel, Ozcan: 3 articles (07/2013 - 11/2003)|
|5.||Bloomer, Richard J: 3 articles (01/2012 - 01/2007)|
|6.||Eum, Hyun-Ae: 3 articles (05/2004 - 12/2002)|
|7.||Fernández-García, Héctor: 2 articles (07/2015 - 05/2010)|
|8.||Fürll, M: 2 articles (01/2014 - 01/2014)|
|9.||Heilig, M: 2 articles (01/2014 - 01/2014)|
|10.||Bäuml, D: 2 articles (01/2014 - 01/2014)|
12/01/2002 - "H-2954 exerted significantly lower protection against ischemia-reperfusion-induced myocardial injury than H-2545, and it was comparable to that of Trolox. "
12/01/2002 - "Trolox C ameliorates hepatic drug metabolizing dysfunction after ischemia/reperfusion."
01/01/2014 - "Trolox inhibited peak and sustained increases in [Ca2+]i during ischemia. "
02/01/2004 - "Effect of Trolox on altered vasoregulatory gene expression in hepatic ischemia/reperfusion."
12/01/1992 - "Thus Trolox C, a lipophilic antioxidant, attenuated myocardial injury during stop-flow ischemia and reperfusion."
09/01/2007 - "Not only are the TSC concentrations needed for radical scavenging greater than those which provide beneficial effects in hemorrhagic shock, but it is also shown that another radical scavenger, trolox, has no effect on oxygen consumption during shock. "
10/01/1996 - "In this study, the efficacy of Trolox (Aldrich Chemical Co., Milwaukee, WI), a water-soluble vitamin E analogue, and ascorbic acid (vitamin C) was evaluated in a rat model of hemorrhagic shock and resuscitation. "
09/15/2010 - "The cytotoxic mechanism comprises a reaction of Trolox with photo-decomposition products of nitrite, which leads to increased Trolox phenoxyl radical formation, increased intracellular oxidative stress, and a consecutive induction of apoptosis and necrosis in fast proliferating T cells. "
11/01/2008 - "Histology showed thick bands of collagen, necrosis and distortion of the hepatic parenchyma in the CCl4 group, such effects were prevented by trolox. "
01/01/1994 - "By comparison, infusion of Trolox (a vitamin E analogue) at 5 mumol/kg produced a higher necrosis of 17.7 +/- 7.2% (n = 6, p < 0.05 vs value obtained from 5 mumol/kg PPG-treated group) in the same model. "
02/01/1985 - "The treatment with Trolox C, in fact, almost completely prevented both liver necrosis and lipid peroxidation, while not changing at all the extent of the covalent binding of bromobenzene metabolites to liver protein."
03/01/1991 - "In both a global and partial model of hepatic ischemia-reperfusion in rats, infusion of Trolox (7.5 to 10 mumol/kg body weight) just before reflow reduced by greater than 80% the liver necrosis sustained in untreated (no Trolox) control rats. "
10/01/2014 - "Furthermore, compared with Trolox, Trolox-CSNPs exert a higher protective effect against the hypoxia-mediated oxidative stress. "
02/01/2014 - "NEU, at a low dose (1 μM), competently depressed the hypoxia-induced convulsive activity in a manner similar to trolox. "
01/01/2014 - "We confirmed in Mecp2 (-) (/y) hippocampus that Trolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves the hypoxia tolerance. "
01/01/2014 - "Furthermore, Trolox specifically attenuated the increased hypoxia susceptibility of Mecp2 (-) (/y) slices. "
10/01/1997 - "These results suggest that Trolox C protected the liver cells against hypoxia/reoxygenation injury, yielding further evidence for a causative role of oxidative stress in this model."
03/01/2009 - "Trolox also possessed membranoprotective properties, being capable of reducing the oxidative hemolysis of erythrocytes."
02/01/2006 - "The total hydroalcoholic extract showed IC(50) 26.96+/-1.53 microg/ml in the DPPH assay, that 10 microg/ml were equivalent to 2.11+/-0.12 microg/ml Trolox (ORAC assay) and IC(50) 1.7+/-0.20 microg/ml in the RBC hemolysis. "
01/01/2003 - "Mechanical fragility tests indicated the Trolox-treated blood in vitro exhibited greater hemolysis than untreated blood in vitro (p < 0.001). "
01/01/2003 - "Biological and environmental factors affecting ultrasound-induced hemolysis in vitro: 3. Antioxidant (Trolox) inclusion."
05/01/1995 - "Hemolysis during storage of RBC concentrates treated with Pc 4 or Pc 5 was drastically reduced by the addition of 5 mM Trolox prior to light exposure. "
|2.||Ascorbic Acid (Vitamin C)
|10.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|2.||Heart Transplantation (Grafting, Heart)
|3.||Photochemotherapy (Photodynamic Therapy)
|5.||Heterologous Transplantation (Xenotransplantation)